Personalis, Inc. current report, 15 November 2022

Business Context and Reporting Period

Company: Personalis, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 15, 2022
Reporting Period: Event-specific report regarding a contract with the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP).

Key Financial Metrics

This filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is related to a specific contract:

  • Contract Value: Up to $10.0 million (initial task order).
  • Condition: Subject to the receipt of samples from the VA MVP.

Material Changes

The filing reports the resolution of a protest regarding a contract awarded in September 2022:

  • Previous Status: A competitive bidder protested the contract award, triggering an immediate work stoppage under Federal Acquisition Regulations.
  • Current Status: On November 15, 2022, the VA MVP notified the Company that the protest was resolved in the Company's favor and the stop-work order has been lifted.

Guidance, Outlook, and Risks

Management Commentary: The Company is now able to resume providing whole genome sequencing services to the VA MVP following the lifting of the stop-work order.
Risks and Contingencies: The revenue from the $10.0 million task order remains contingent upon the actual receipt of samples from the VA MVP. The filing does not provide updated revenue guidance or discuss other material risks beyond the resolved protest.

Key Facts for Investor Verification

  • Verify the timeline for the resumption of work and sample receipt from the VA MVP.
  • Confirm the specific terms of the $10.0 million task order and any potential for additional task orders under the contract.
  • Assess the impact of the work stoppage period on the Company's ability to meet delivery schedules or recognize revenue in the current fiscal period.